Pantoprazole 40 Mg Tablet For Pharma Franchise

₹ 800/Box

FormTablet
Strength40 mg
Packaging Size10*10 Tablets
Packaging TypeStrips
CompositionPantoprazole 40mg
Usage/ApplicationTo neutralize excessive acid in the stomach
Prescription/Non-PrescriptionPrescription
Also GivesPCD Pharma Franchise
AvailabilityIn Stock
Pantoprazole 40mg tablet is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough.

Find products similar to Pantoprazole 40 Mg Tablet For Pharma Franchise

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromKanpur
ShippingAs per delivery location

Product Image

Pantoprazole 40 Mg Tablet For Pharma Franchise-1Pantoprazole 40 Mg Tablet For Pharma Franchise-2Pantoprazole 40 Mg Tablet For Pharma Franchise-3Pantoprazole 40 Mg Tablet For Pharma Franchise-4

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
01-07-2017
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Jan 2013
GST
09AAKCS4757P1ZD
Import Export Code (IEC)
AAKCS*****

Established in the year of 2007. We ”Shiny Pharmaceutical Private Limited” are a leading Wholesaler/Distributor We ”Shiny Pharmaceutical Private Limited” are Leading Wholesaler/Distributor of Pharmaceutical Tablets, Capsules, Syrups, Ayurvedic, Injectables, Powders, PCD and herbal Pharma Franchise etc.

We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to Our CEO Vishal Gupta whose continual backing and direction have been useful to us for attaining exponential development in the current market